Insys Therapeutics, Inc.

Insys Therapeutics, Inc., incorporated on June 15, 1990, is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. Subsys is the Company’s marketed product. Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and is a single-use product that delivers fentanyl, an opioid analgesic, for transmucosal absorption underneath the tongue. The Company markets Subsys through its field sales force focused on supportive care physicians in the United States.Subsys Sublingual Fentanyl SprayThe Company’s product, Subsys, delivers a liquid fentanyl formulation in approximately

Bank Name Insys Therapeutics, Inc.
Stock Exchange NASDAQ
Symbol INSY
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
Chairman Mr. Steven J. Meyer
CEO Mr. Saeed Motahari
Employees 343
Registered Year